Navigation Links
Swift Transportation donates more than $15,000 to the Waylon Fund
Date:12/13/2012

PHOENIX, Ariz. Dec. 13, 2012 Swift Charities, the charitable arm of Swift Transportation, today donated $15,262 to The Waylon Jennings Fund for Diabetes Research at the Translational Genomics Research Institute (TGen).

Throughout November Diabetes Awareness Month The Waylon Fund was Swift's "charity of choice." Half of November's proceeds from thousands of driver donations, as well as matching contributions from Phoenix-based Swift, were collected to benefit TGen's diabetes research in the name of country music legend Waylon Jennings.

In a letter to Swift drivers, Jennings' widow, Jessi Colter, urged them to remember her late husband, who died in 2002 of complications from diabetes, a disease that affects nearly 26 million Americans.

"Waylon Jennings was truly one-of-a-kind. Often thought of as an 'outlaw' and a mentor to a new generation of country and rock acts inspired by his spirit and individualism, he was above all someone who stood strong in the face of adversity," Colter said in her letter. "I am so pleased to announce TGen's new partnership with Jerry Moyes, the founder, chairman and CEO of Phoenix-based Swift Transportation. With the help of Swift Charities and Swift drivers from across the country, The Waylon Fund will spur innovative research at TGen to find better treatments for diabetes."

Jim Stone, Executive Director of Swift Charities, said his company's drivers were eager to answer Colter's call to action.

"Diabetes is one of many health issues that needs greater attention, and we at Swift are proud to partner with another Phoenix-based institution, TGen, to advance biomedical research in this critical area," Stone said. "To be able to do that in conjunction with Jessi Colter, and do it in the memory of Waylon Jennings, that is a real honor."

"TGen's research into diabetes will allow physicians to more accurately predict who has the greatest risk of developing Type 2 diabetes and related complications, while also identifying targets for treatment of the disease," said Dr. Johanna DiStefano, Director of TGen's Diabetes, Cardiovascular & Metabolic Diseases Division.

Dr. DiStefano leads a team of scientists working in five areas of research: diabetes and heart disease, diabetic nephropathy, diabetes and obesity, diabetes and liver disease, and diabetes and individualized treatment strategies.

"TGen is extremely grateful to the Swift Transportation family for supporting The Waylon Fund for Diabetes Research," said Michael Bassoff, President of the TGen Foundation. "This gift from Swift Charities is reflective of the dedication and generosity of Swift employees nationwide who individually contributed to help accelerate TGen's diabetes research."


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Jeff Crandall Honored With SAE International Arnold W. Siegel International Transportation Safety Award
2. To spread, nervous system viruses sabotage cell, hijack transportation
3. Plan to turn farm waste into paper earns students $15,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... 23, 2016 ReportsnReports.com adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology: